Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.6M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
83.7M
-
Shares change
-
-535K
-
Total reported value, excl. options
-
$1.25B
-
Value change
-
-$7.69M
-
Put/Call ratio
-
1.54
-
Number of buys
-
120
-
Number of sells
-
-80
-
Price
-
$14.91
Significant Holders of Pediatrix Medical Group, Inc. - Common Stock (MD) as of Q1 2023
237 filings reported holding MD - Pediatrix Medical Group, Inc. - Common Stock as of Q1 2023.
Pediatrix Medical Group, Inc. - Common Stock (MD) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.7M shares
of 87.6M outstanding shares and own 95.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13.5M shares), VANGUARD GROUP INC (9.95M shares), LAZARD ASSET MANAGEMENT LLC (8.14M shares), ALLIANCEBERNSTEIN L.P. (7.93M shares), EARNEST PARTNERS LLC (6.56M shares), DIMENSIONAL FUND ADVISORS LP (3.86M shares), STATE STREET CORP (3.42M shares), ArrowMark Colorado Holdings LLC (2.64M shares), River Road Asset Management, LLC (1.59M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.55M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.